Patents

US6734309: Process for the synthesis of isonicotinic acid hydrazide

The invention provides a process for the manufacture of Isonicotinic Acid Hydrazide(INH) useful in the treatment of tuberculosis. The invention relates to the single step conversion of isonicotinamide by hydrazine hydrate to Isonicotinic Acid Hydrazide (INH) of yield greater than 95% (w/w) and purity more than 99%.

Filing Date: 20-03-2003

Issue Date: 11-05-2004

Applicant: CSIR-Central Institute of Mining and Fuel Research (CSIR-CIMFR), Dhanbad

Patent No: US6734309

Application No: 10/393372

Inventor(s): Ray, Subhash Chandra (Dhanbad, In); Nandi, Lakshmi Narayan (Dhanbad, In); Singh, Baldev (Dhanbad, In); Prasad, Hiralal (Dhanbad, In); Maharaj, Sumant (Dhanbad, In); Sarkar, Prodyot Kumar (Dhanbad, In); Dutta, Pashupati (Dhanbad, In); Roy, Shyam Kishore (Dhanbad, In); Yadav, Satya Niketan (Dhanbad, In); Bandyopadhyay, Anup Kumar (Dhanbad, In)

IPC Classification: C07D 213/56

Country: United States of America

Related Patents

AU2008352536: A process for the preparation of primary alkyl glycerol ethers useful as biofuel additive from glycerol
AU2011306643: Top2A inhibition by temozolomide and its predictive value of GBM patient's survival
CA2659782: An exact algebraic formula for the impulse response of a plane acoustic reflector at zero offset due to a point acoustic source
DE1682672: A method for the detection of predisposition to high altitude pulmonary edema(hape)
DE2638047: Substituted 4 -acrylamidopodophyllotoxin congeners as antitumour antibiotics and process for the preparation thereof